… to the active substance or to any of the excipients listed in section 6.1.
Recent myocardial infarction. Any degree of heart block or disorders of cardiac rhythm and coronary artery insufficiency.
Concomitant treatment with MAOIs (monoamine oxidase inhibitors) is contra-indicated (see section 4.5). Simultaneous administration of amitriptyline and MAOIs may cause serotonin syndrome (a combination of symptoms, possibly including agitation, confusion, tremor, myoclonus and hyperthermia).
Treatment with amitriptyline may be instituted 14 days after discontinuation of irreversible non- selective MAOIs and minimum one day after discontinuation of the reversible moclobemide. Treatment w …
Identical in all 6 labels. Surrounding text shown from Brown & Burk UK Ltd.
… to the active substance or to any of the excipients listed in section 6.1.
Recent myocardial infarction. Any degree of heart block or disorders of cardiac rhythm and coronary artery insufficiency.
Concomitant treatment with MAOIs (monoamine oxidase inhibitors) is contra- indicated (see section 4.5). Simultaneous administration of amitriptyline and MAOIs may cause serotonin syndrome (a combination of symptoms, possibly including agitation, confusion, tremor, myoclonus and hyperthermia).
Treatment with amitriptyline may be instituted 14 days after discontinuation of irreversible non-selective MAOIs and minimum one day after discontinuation of the reversible moclobemide. Treatment wi …
Identical in all 3 labels. Surrounding text shown from Strides Pharma UK Ltd.
… n. Any degree of heart block or disorders of cardiac rhythm and coronary artery insufficiency.
Concomitant treatment with MAOIs (monoamine oxidase inhibitors) is contra-indicated (see section 4.5).
Simultaneous administration of amitriptyline and MAOIs may cause serotonin syndrome (a combination of symptoms, possibly including agitation, confusion, tremor, myoclonus and hyperthermia).
Treatment with amitriptyline may be instituted 14 days after discontinuation of irreversible non-selective MAOIs and minimum one day after discontinuation of the reversible moclobemide. Treatment wi …